Glutamate Receptor and Kynurenine Pathway Functioning in the Pathobiology of Gulf War Illness

Abstract

This project examines inflammatory pathway biomarkers obtained from cerebrospinal fluid (CSF) collected from 46 1990-1991 Gulf War veterans with and 23 without Gulf War Illness, and test effects of N-methyl-D-aspartate receptor (NMDAR) antagonist ketamine on symptoms of Gulf War Illness in 19 cases and 19 controls. In the last period we focused on subject recruitment. On November 29, 2018, accessed information of local veterans from the 1990-1991 Gulf War registry. Using registry information, we send recruitment letters to 92 veterans as of December 31, 2018. Of the 92, we contacted by phone 42 veterans; an additional 5 veterans were referred to the study through other sources. Of the 47 veterans, 12 were phone screened. Two met initial inclusion criteria and agreed to a lumbar puncture for CSF collection. One was a screen fail due to excluding medical conditions, and one is completing screening. Our project is behind schedule of subject recruitment, in part because veterans do not agree to the lumbar puncture. In the coming year we will continue subject recruitment, as well as amend the protocol to access other resources for study-related biomarkers, including (i) biomarkers collected from blood, and (ii) accessing CSF biorepositories.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2018
Accession Number
AD1094737

Entities

People

  • Marijn Lijffijt

Organizations

  • Baylor College of Medicine

Tags

DTIC Thesaurus Topics

  • Biological Markers
  • Biomedical Research
  • Biorepositories
  • Department Of Defense
  • Electronic Mail
  • Glutamates
  • Governments
  • Inclusions
  • Inflammation
  • Institutional Review Board
  • Ketamine
  • Kynurenine
  • Local Governments
  • Patent Applications
  • Persian Gulf Syndrome
  • Professional Development
  • Training

Readers

  • Clinical Trial Research.
  • Neurotrauma and Rehabilitation Medicine.
  • Psychological Intervention/Treatment for Stress, Anxiety, PTSD, and Related Emotional and Cognitive Health Symptoms.